News & Updates

Patients who undergo complete revascularization with percutaneous coronary intervention following a myocardial infarction (MI) are at lower risk of all-cause mortality, cardiovascular mortality, MI, major adverse cardiac events (MACE), and repeat revascularization, reports a recent study.

In the treatment of patients with type 2 diabetes (T2D) and obesity, metabolic/bariatric surgery appears to produce sustained weight loss over 12 years, translating to better physical function, general health, and vitality, as well as reduced pain, according to long-term data from the ARMMS-T2D Study.

Latest findings from the ongoing phase III NATALEE trial have shown that 3-year treatment with adjuvant ribociclib, in combination with a nonsteroidal aromatase inhibitor (NSAI), remained well tolerated in patients with HR+/HER2- early-stage breast cancer (EBC).

Poor glycaemic control appears to contribute to coronary stent failure driven by in-stent restenosis in patients with type 2 diabetes (T2D), suggests a study.